Hearing, Acousia

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

07.08.2025 - 18:05:30 | prnewswire.co.uk

Acousia Therapeutics GmbH Germany

en | boerse | 67969965 |